CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 253 enrolled
Drug / intervention
Home-based human papillomavirus (HPV) DNA screening +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03489707
NCT03489707N/ACompleted
CompareCT.gov

Annual Anal Sampling Using DNA Screening to Identify Men Who Have Sex With Men at Increased Risk for Anal Cancer

Medical College of Wisconsin·interventional·Posted Apr 5, 2018·Updated Nov 12, 2024

In Brief

A clinical study evaluating Home-based human papillomavirus (HPV) DNA screening and Clinic-based human papillomavirus (HPV) DNA screening for Anal Cancer. Completed, enrolled 253 participants across 1 site.

Detailed Summary

The purpose of this research study is to find ways to screen for anal cancer among gay, bisexual, and other men who have sex with men (MSM) and transgender persons. This study will try to find out if persons will do annual anal cancer screening, what factors are associated with repeated screening, and how this affects a person's decision to have high-resolution anoscopy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnal Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI), The University of Texas Health Science Center, Houston, M.D. Anderson Cancer Center

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedApr 5, 2018
Enrollment StartJan 9, 2020
Primary CompletionAug 31, 2023
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 8.2 years ago

Interventions

Home-based human papillomavirus (HPV) DNA screeningbehavioral

Persons randomized to arm 1 will receive an HPV DNA home-based collection kit in the mail at 0 and 12 months.

Clinic-based human papillomavirus (HPV) DNA screeningbehavioral

Persons randomized to arm 2 will attend a clinic where a clinician will collect the DNA specimen at 0 and 12 months.